TransBiotec Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
2017
Cost of Goods Sold (COGS) incl. D&A
0.60
0.80
0.80
0.50
-
-
Gross Income
0.60
0.80
0.80
0.50
-
-
SG&A Expense
2,886.70
783.80
505.60
447.00
396.10
313.10
EBIT
2,887.30
784.60
506.30
447.40
396.10
313.10
Unusual Expense
448.10
286.00
21.60
25.90
-
12
Non Operating Income/Expense
4.80
-
-
-
-
-
Interest Expense
230.30
264.60
221.00
275.30
203.10
317.20
Pretax Income
3,560.90
763.20
748.90
696.70
599.20
642.30
Consolidated Net Income
3,560.90
763.20
748.90
696.70
599.20
642.30
Net Income
3,553.30
758.40
744.60
691.70
595.10
639.10
Net Income After Extraordinaries
3,553.30
758.40
744.60
691.70
595.10
639.10
Net Income Available to Common
3,553.30
758.40
744.60
691.70
595.10
639.10
EPS (Basic)
0.13
0.02
0.02
0.01
0.01
0.01
Basic Shares Outstanding
28,275.10
32,540.60
39,215.90
59,261.10
67,320.70
97,823.50
EPS (Diluted)
0.13
0.02
0.02
0.01
0.01
0.01
Diluted Shares Outstanding
28,275.10
32,540.60
39,215.90
59,261.10
67,320.70
97,823.50
EBITDA
2,886.70
783.80
505.60
447.00
396.10
313.10
Minority Interest Expense
7.60
4.80
4.40
5.00
4.10
3.20
About TransBiotec
View Profile
